Basic Information
Subsense develops biocompatible nanoparticles for tracking brain activity. The company's devices assist in paralysis and neurological disorders, treat neurological and neurodegenerative diseases, and enable human-computer interaction machines and bidirectional brain-computer interfaces, improving lives in healthcare and redefining the interaction between human cognition and technology.
Subsense
California,United States of America
less than 15 people
January 01, 2022
ta@subsense-bci.com

